IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Research & Development data on file, last reported at $95.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 35.04% year-over-year to $95.7 million; the trailing twelve-month figure through Mar 2026 stood at $290.0 million (up 82.02% YoY), and the FY2025 full-year result was $314.7 million, up 277.24% from the prior year.
• Research & Development rose to $95.7 million in Q1 2026, from $86.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $95.7 million in Q1 2026 to a low of -$45.1 million in Q4 2023.
• A 5-year average of $33.8 million and a median of $29.2 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development sank 271.4% in 2022 and jumped 633.77% in 2025, its largest moves.
• Tracing IDYA's Research & Development over 5 years: stood at -$27.6 million in 2022, then plunged by 63.32% to -$45.1 million in 2023, then surged by 126.17% to $11.8 million in 2024, then jumped by 633.77% to $86.6 million in 2025, then gained by 10.54% to $95.7 million in 2026.
• Business Quant data shows IDYA's Research & Development at $95.7 million in Q1 2026, $86.6 million in Q4 2025, and $33.4 million in Q3 2025.